Micro Labs

Research Development

R&D Capabilities

We are committed to doing world class research that develops Bio-equivalent Generics.

A focused effort in defined areas and a lasting interest in new technology are key features of our efforts to develop NDDS & innovative combination products in the medium - long term.

Micro R&D centre is an integrated set up with 8 research centres & 3 new ones in construction phase.

Out of which 6 are fully functional and 2 formulation R&D centres (Mumbai and Chandigarh ) will be operational by end of 2007

Analytical facilities which range from compound identification to bio-analytical capabilities consisting of all modern equipments

The research team comprises of 136 Scientists / Pharmacists / Analysts / Chemists / Microbiologists engaged in product & analytical development.

Formulations

Design and develop pharmaceutical products of International Standards including

	Enteric coated tablets
	Chewable tablets
	Dispersible tablets
	Capsules
	Powders
	Dry syrups for reconstitution

R&D Finished Products

Conceiving and identifying product profile
Pre formulation studies
Lab formula development and development for stability & validation
Scale up for process optimization/ validation
Analytical method development
Pilot scale mfg in cGMP facility (Clinical supplies)
Stability studies as per ICH guidelines
Dossier preparation for submission/Technical assistance for contract manufacturing
Data management (for transfer to customer/ regulatory Affairs)

R&D Facility

Development of Generics.
Strict Compliance IPR / Non-infringing roots.
Infrastructure includes facility for scale-up & validation.
Target pharmacopieal store levels.
Capability includes handling complex chemistries.
Regulatory complaint development & scale-up.
File EU-DMF / E-COS / US-DMF
8 Molecules under development

Dosage forms & Technologies:

Immediate Release Solid Dosage Form (IR)

Sustained Release tablet Technology (DR)

Effervescent Technology

Enteric Coated Technology

Direct Compression Technology